Enterprise Telehealth RFPs Now Require FHIR and AI Documentation as Table Stakes

FHIR Integration Moves from Nice-to-Have to Contract Requirement

Enterprise telehealth buyers in 2026 are rejecting platforms that rely on custom HL7 interfaces, according to newly published industry research on what CIOs and CMOs are actually procuring. Platforms must now demonstrate bidirectional, FHIR-native integration into Epic, Oracle Health (formerly Cerner), athenahealth, Allscripts, and Meditech as a hard contract requirement. Vendors still dependent on point-to-point HL7 integrations are losing deals at the RFP stage.

The shift reflects a fundamental change in how health systems treat telehealth infrastructure. Buyers now evaluate telehealth platforms against the same data-posture standards they apply to core systems of record. This means multi-tenant SaaS with row-level isolation, encryption at rest, customer-managed keys, full audit logging, and HIPAA business associate agreements. InfoSec teams are applying financial-services-grade scrutiny to telehealth vendors, elevating regulatory and breach risk for platforms that cannot meet these baselines.

AI Documentation and Prior Authorization Become Core Features

AI capabilities are no longer experimental add-ons in enterprise telehealth RFPs. Buyers explicitly evaluate ambient clinical documentation (Abridge, Suki, DeepScribe, Microsoft DAX Copilot), clinical decision support, and prior-authorization automation as core platform features. This requirement effectively disqualifies lightweight video-visit tools and older standalone platforms that lack deep AI integration.

The implication for budgets is direct: telehealth line items must now include both platform licensing and AI module costs as core operational spend, not innovation experiments. This moves telehealth purchasing into the same budget category as EHR and CRM platforms. Health systems that previously allocated $100K–$200K for telehealth now face combined platform-plus-AI costs approaching $400K+ annually for Tier 1 health-system deployments.

Vendors bundling AI workflows—Amwell, Teladoc, Epic-embedded telehealth modules, and platforms integrating DAX Copilot or Abridge—gain an advantage over portal-based tools like Doxy.me and SMB-focused telemedicine platforms. The latter group lacks both the FHIR depth and AI integration enterprise RFPs now screen for.

Build Economics Shift the Buy-vs-Build Decision

New cost benchmarks for custom telehealth platforms change the economics of build-versus-buy for payers and multi-region health systems. A Tier 1 MVP platform—video visits, scheduling, e-prescribing, and EMR synchronization—can now be built in 12–16 weeks for $40K–$90K, down from prior assumptions of $500K. A HIPAA-compliant MVP with consultation features typically costs $50K–$100K over 8–16 weeks.

Tier 3 enterprise platforms—SSO to hospital identity providers, native iOS and Android apps, multi-tenant white-label architecture, HITRUST CSF certification, deep Epic App Orchard listing, self-hosted media stack, and 24/7 site reliability engineering—require 9–14 months and $400K or more. Complex platforms with remote patient monitoring, AI intake, and multi-EHR connectivity reach $200K–$400K over 28–52 weeks. Multi-region, multi-regulatory enterprise ecosystems with full API layers exceed $400K and can extend beyond 12 months.

For payers, insurers, and large employers with multi-payer, multi-region needs, the new guidance is explicit: build, do not buy. Commercial platforms lack the analytics and authorization hooks these buyers require. Regional health systems serving fewer than three states or those without multi-tenant white-label requirements still favor commercial SaaS, but the build path is now economically viable for mid-market organizations.

Lower MVP price points put development agencies and system integrators in direct competition with SaaS vendors like Teladoc, Amwell, and Doxy.me for mid-market and regional accounts. High-end Tier 3 costs highlight that few SaaS vendors truly deliver health-system-grade multi-tenant white-label capabilities with deep Epic App Orchard integrations, differentiating those that do from commodity offerings.

What Enterprise Buyers Must Do Now

RFPs must explicitly screen for SMART-on-FHIR app launch, bidirectional FHIR APIs, and embedded AI documentation. Platforms without these capabilities will be disqualified early. Budget planning must account for both platform license costs and AI module costs as core telehealth spend, raising annual allocations into the $400K+ range for Tier 1 health systems.

InfoSec teams should treat telehealth vendors like core systems of record. Platforms without customer-managed keys, row-level isolation, and full audit trails increase regulatory and breach risk and will face heavier scrutiny during procurement. Health systems with multi-region, multi-regulatory, or multi-payer requirements should evaluate custom builds against commercial SaaS, using the new $400K+ and 9–14 month benchmarks for Tier 3 platforms as a baseline.

The global telehealth market is expected to grow from $153.84 billion in 2025 to $191.88 billion in 2026, implying roughly 21–25% compound annual growth. That growth is concentrating in platforms that meet the new FHIR, AI, and data-posture baselines. Buyers who defer these requirements will find themselves locked into platforms that cannot meet enterprise RFP standards within 18 months.